Status:
UNKNOWN
Changes After Suprachoroidal Injection.
Lead Sponsor:
Benha University
Conditions:
Retina; Change
Intraocular Pressure
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Changes after suprachoroidal injection are analyzed for statistical analysis.
Detailed Description
Changes after suprachoroidal injection of triamcinolone acetonide are noted in various retinal diseases treated by this technique to address its effects over six months of follow-up.
Eligibility Criteria
Inclusion
- Patients prepared to suprachoroidal injection for various retinal diseases will be enrolled in the study.
- Bilateral retinal diseases that required interventions as diabetic macular edema, exudative retinal detachment, and serous chorioretinopathies.
Exclusion
- Other retinal diseases that are not expected to improve after steroid injections as central retinal artery occlusion and age-related macular degenerations.
- Choroidal neovascularization that require anti-vascular endothelial growth factors.
- Patients refused to have steroid injections even after discussing the nature of their disease with them and the procedure to be done.
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05288192
Start Date
February 15 2022
End Date
September 1 2022
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha University
Banhā, QA, Egypt, 13511